UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
Full name: Instillagel 20,9 mg/ml Gel
- Invented Name Part: Instillagel
- Strength part: 20,9 mg/ml
- Pharmaceutical dose form part: Gel
Name usage: Swedish (Kingdom of Sweden)
Authorised dose form: Gel
Legal status of supply: Medicinal product subject to medical prescription
Domain: Human use
Resource status: Current
Product classification:
Marketing Authorisation 1 of 1
Authorisation number: 10132
Region: Kingdom of Sweden
Marketing authorisation holder: Farco-Pharma GmbH
Identifier:
Status: Valid (1984-11-01)
Package 1 of 1
PCID:
Description: Engångsspruta, 10 x 11 ml
Marketing status:
Pack size:
Package: 1 Box (Cardboard)
Containing:
Package: 10 Unit-dose blister (Paper) (PolyPropylene)
Containing:
Package: 1 Pre-filled syringe (PolyPropylene)
Containing: 11 millilitre(s)
Manufactured Item
Dose form: Gel
Unit of presentation: Syringe
Ingredient
Role: Active
Substance: Lidocaine hydrochloride monohydrate
Concentration strength: 22.9 milligram(s) / 1 millilitre(s)
Reference strength: Lidocaine hydrochloride 20.9 milligram(s) / 1 millilitre(s)
Reference strength: Lidocaine 18.09 milligram(s) / 1 millilitre(s)
Administrable Product (1 of 1)
Dose form: Gel
Unit of presentation:
Route of administration:
Ingredient
Role: Active
Substance: Lidocaine hydrochloride monohydrate
Concentration strength: 22.9 milligram(s) / 1 millilitre(s)
Reference strength: Lidocaine hydrochloride 20.9 milligram(s) / 1 millilitre(s)
Reference strength: Lidocaine 18.09 milligram(s) / 1 millilitre(s)